Drug reference

lurbinectedin

Mosby’s 2024 Nursing Drug Reference

Review source pages for extracted sections and age labels.

Overview

(loor′bin-ek′te-din) Zepzelca

PDF page 823

Func. class.: Antineoplastic, alkylating agent

PDF page 823

USES: Treatment of metastatic small cell lung cancer with disease progression after platinum-type chemotherapy

PDF page 823

CONTRAINDICATIONS: Hypersensitivity

PDF page 823

DOSAGE AND ROUTES Small cell lung cancer, metastatic Adult: IV: 3.2 mg/m2 q21days until disease progression/unacceptable toxicity

PDF page 823

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Mosby’s 2024 Nursing Drug Reference

Review source pages for extracted sections and age labels.

(loor′bin-ek′te-din) Zepzelca

PDF page 823

Func. class.: Antineoplastic, alkylating agent

PDF page 823

USES: Treatment of metastatic small cell lung cancer with disease progression after platinum-type chemotherapy

PDF page 823

CONTRAINDICATIONS: Hypersensitivity

PDF page 823

DOSAGE AND ROUTES Small cell lung cancer, metastatic Adult: IV: 3.2 mg/m2 q21days until disease progression/unacceptable toxicity

PDF page 823

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.